These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 430548)

  • 1. Evaluation of the lysostaphin-susceptibility test for the classification of staphylococci.
    Heddaeus H; Heczko PB; Pulverer G
    J Med Microbiol; 1979 Feb; 12(1):9-15. PubMed ID: 430548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification and lysostaphin susceptibility of airborne staphylococci.
    Terayama K; Hirata F; Ohno H; Kawarabayashi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):313-6. PubMed ID: 6618426
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysostaphin disk test for routine presumptive identification of staphylococci.
    Poutrel B; Caffin JP
    J Clin Microbiol; 1981 Jun; 13(6):1023-5. PubMed ID: 7019233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid lysostaphin test to differentiate Staphylococcus and Micrococcus species.
    Geary C; Stevens M
    J Clin Microbiol; 1986 Jun; 23(6):1044-5. PubMed ID: 3519667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BiTek agar on lysostaphin susceptibility of staphylococci.
    Langlois BE; Dawson K; Akers K
    J Clin Microbiol; 1990 Nov; 28(11):2568-9. PubMed ID: 2254432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
    DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL
    Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme.
    Cisani G; Varaldo PE; Grazi G; Soro O
    Antimicrob Agents Chemother; 1982 Apr; 21(4):531-5. PubMed ID: 7081976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid identification of Staphylococcus aureus by using lysostaphin sensitivity.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Jun; 11(6):724-7. PubMed ID: 7430338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies with lysostaphin. I. Lysostaphin sensitivity of 355 strains of Staph. aureus of human origin].
    Pulverer G
    Z Med Mikrobiol Immunol; 1968; 154(1):40-8. PubMed ID: 5710870
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of various methods for differentiation of staphylococci and micrococci.
    Baker JS
    J Clin Microbiol; 1984 Jun; 19(6):875-9. PubMed ID: 6381527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic activities of coagulase-positive staphylococci.
    Balusek J; Hájek V
    J Hyg Epidemiol Microbiol Immunol; 1985; 29(2):147-54. PubMed ID: 4020118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sensitivity to lysostaphin lysis of staphylococci isolated from ovine mastitic milk].
    Gutiérrez L; Garciá ML; Moreno B
    Microbiol Esp; 1981; 34():17-28. PubMed ID: 7200189
    [No Abstract]   [Full Text] [Related]  

  • 13. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.
    Boksha IS; Lavrova NV; Grishin AV; Demidenko AV; Lyashchuk AM; Galushkina ZM; Ovchinnikov RS; Umyarov AM; Avetisian LR; Chernukha MIu; Shaginian IA; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2016 May; 81(5):502-10. PubMed ID: 27297900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    King BF; Biel ML; Wilkinson BJ
    Infect Immun; 1980 Sep; 29(3):892-6. PubMed ID: 7429637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of various blood culture media on lysostaphin sensitivity of staphylococci.
    Severance PJ; Kauffman CA; Sheagren JN
    J Clin Microbiol; 1980 Nov; 12(5):709-10. PubMed ID: 7276143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of phagocytosis of Staphylococcus aureus with the aid of lysostaphin (author's transl)].
    Dörner I; Blobel H; Schaeg W
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):141-6. PubMed ID: 848206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Lif, the lysostaphin immunity factor, on acceptors of surface proteins and cell wall sorting efficiency in Staphylococcus carnosus.
    Strauss A; Thumm G; Götz F
    J Bacteriol; 1998 Sep; 180(18):4960-2. PubMed ID: 9733703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Staphylococcus epidermidis to lysostaphin and major antimicrobial agents.
    Pulverer G; Jeliaszewicz J
    Chemotherapy; 1973; 19(2):109-14. PubMed ID: 4762803
    [No Abstract]   [Full Text] [Related]  

  • 20. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.